Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

Total article views   HTML views PDF downloads Totals
3,067 Dovepress* 2,439+ 81 2,520
PubMed Central* 628 224 852
Totals 3,067 305 3,372
*Since 18 September 2023

View citations on PubMed Central and Google Scholar